C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/14 (2006.01) A61K 31/506 (2006.01) A61P 3/00 (2006.01)
Patent
CA 2749994
A new polymorphic form of 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5- {[(1S)-1-methyl-2- (methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide, processes for making it and its use as an activator of glucokinase are described.
La présente invention porte sur une nouvelle forme polymorphe du 3-{[5-(azétidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-méthyl-2-(méthyloxy)éthyl]oxy}-N-(5-méthylpyrazin-2-yl)benzamide, sur des procédés permettant de la fabriquer et sur son utilisation comme activateur de la glucokinase.
Assarsson Karin
Bowden Sharon Ann
Hoile David Peter
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Crystalline polymorphic form 631 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline polymorphic form 631, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline polymorphic form 631 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1392004